BASEL, Switzerland: Now that the first half of 2020 is over, the Straumann Group has reported that the SARS-CoV-2 crisis has reduced its revenue by 22% to CHF 605 million (€562 million), compared with the first half of 2019. Dental practices closed in many parts of the world, and business declined drastically in mid-March, reaching a trough in April. When lockdown measures began to ease and dental practices reopened, sales began to climb in May, and this trend continued through June. Whereas the pandemic hit all markets, the extent of the impact varied in different regions.
BASEL, Switzerland: The Straumann Group has put its support behind clinician-led clear aligner therapy by acquiring a majority share in Berlin-based DrSmile. Straumann has committed to additional investment in DrSmile and says that, together, the two companies will offer growth opportunities to partner dentists.
After tooth extraction, a series of physiological changes affecting the surrounding alveolar bone take place. This process includes bone formation as well as volumetric resorption, and the latter can compromise implant placement in a prosthetically driven position or the clinical outcome. In an upcoming webinar, which will be broadcast live on 7 July, Drs Susy Linder and Michel Dard will explain the clinical decision-making process after tooth extraction. Prior to the online presentation, the experts answered a few questions for Dental Tribune International on the use of biomaterials in this regard.
lass aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Aenean quis malesuada massa, sed congue ligula. Phasellus luctus, diam et dapibus vehicula, ipsum elit consequat eros, ac varius mi arcu ut turpis. Nullam eget mi quam. Ut eget arcu non leo bibendum bibendum. Etiam consequat vestibulum vehicula.